Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Articles by Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP
Optimizing Multidisciplinary Collaboration in CKD Management
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Learn how uACR and eGFR tracking, EHR prompts, and team-based titration streamline early CKD care and reduce cardiovascular risk.
Clinical and Biomarker Signals for Escalating Therapy in High-Risk CKD
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP See how UACR trends motivate patients, guide shared decisions, and tailor therapies to slow CKD while lowering cardiovascular risk.
Tailoring CKD Management to Cardiovascular Risk and Multidisciplinary Monitoring
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Heart failure playbook reshapes CKD care: early combo therapies, right dosing, and smart uACR/eGFR follow-up to boost adherence.
Approaches to Prioritizing and Sequencing Therapies in CKD
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Explore the four-pillars approach to slowing kidney disease—max dose ACE/ARB, add SGLT2, MRA, GLP‑1—plus access and team-based tips.
Guiding CKD Treatment Decisions with uACR and eGFR Trends
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Learn how KDIGO risk staging and urine ACR guide CKD management, triage, and timely nephrology referral when red flags appear.
Unmet Needs Remaining in CKD Diagnosis
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Clinicians rethink cardio-renal care: educate teams, streamline workflows, expand screening via pharmacists and EHRs, and prioritize prevention over dialysis.
uACR and eGFR Testing in CKD: Addressing Barriers and Patient Communication
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Why uACR urine testing lags: incentives, workflow gaps, and silos—and how KDIGO staging strengthens kidney and cardiovascular risk conversations.
Evaluating Clinical Gaps in Combining uACR and eGFR Testing in CKD Diagnosis
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Learn why pairing eGFR with urine albumin-creatinine ratio improves CKD screening, avoids missed diagnoses, and guides follow-up care.
Combined Role of Estimated Glomerular Filtration Rate (eGFR) and Urine Albumin-Creatinine Ratio (uACR) Testing in CKD
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Learn how UACR testing complements eGFR, reveals hidden kidney and cardiovascular risk, and uses a color-coded heat map to guide patient communication and referrals.
Emphasizing Multidisciplinary Collaboration for Early CKD Diagnosis
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Clinicians across specialties share responsibility for early kidney disease screening—use UACR and eGFR at every touchpoint to prevent patients slipping through cracks.
Understanding the Link Between Early CKD Diagnosis and Cardiovascular Outcomes
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Why CKD screening lags despite aligned KDIGO, ADA and hypertension guidance—use eGFR plus UACR staging and EHR prompts to act earlier.
Quality of Life Impact of Delayed CKD
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP CKD guidelines agree: use eGFR plus UACR for KDIGO staging, but screening lags—see how teams and EHRs close the gap.
CKD Guidelines and Adherence Across Specialties
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Experts explain how uACR and eGFR testing reveals hidden CKD, links to heart risk, and guides early, patient-centered care.
Addressing Chronic Kidney Disease (CKD) Prevalence and Patient Awareness in Cardiorenal Metabolic Care
ByMuthiah Vaduganathan, MD, MPH,Nihar R. Desai, MD, MPH,Pamela Kushner, MD, FAAFP ,Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPS-AQ Cardiology, CACP Learn how uACR and eGFR uncover hidden CKD, sharpen cardiovascular risk, and guide patient-friendly conversations for earlier, smarter care.
